-
1
المؤلفون: Shinji Nakamichi, Kaoru Kubota, Fenfei Zou, Anna Hayashi, Natsuki Takano, Naomi Onda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Masahiro Seike
المصدر: International Journal of Clinical Oncology.
مصطلحات موضوعية: Oncology, Surgery, Hematology, General Medicine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2b31a1ad52e04681c10c05f95bfae310Test
https://doi.org/10.1007/s10147-023-02343-9Test -
2
المؤلفون: Vytautas Getautis, Tadas Malinauskas, Lauryna Monika Svirskaite, Shinji Nakamichi, Christoph Lungenschmied, Ingmar Bruder, Maryte Daskeviciene, Ernestas Kasparavicius, Mantas Marcinskas
المصدر: Journal of Electronic Materials. 48:5843-5849
مصطلحات موضوعية: 010302 applied physics, Photocurrent, Materials science, business.industry, Detector, Near-infrared spectroscopy, Photodetector, 02 engineering and technology, 021001 nanoscience & nanotechnology, Condensed Matter Physics, 01 natural sciences, Electronic, Optical and Magnetic Materials, law.invention, Wavelength, law, 0103 physical sciences, Solar cell, Materials Chemistry, Optoelectronics, Molecule, Electrical and Electronic Engineering, 0210 nano-technology, business, Absorption (electromagnetic radiation)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::18c6933d4186dfb5083980737f203ecaTest
https://doi.org/10.1007/s11664-019-07375-4Test -
3
المؤلفون: Tomohide Tamura, Kohei Inoue, Akiko Harada, Hiroshi Nokihara, Noboru Yamamoto, Satoru Kitazono, Yoshito Takeuchi, Shinji Nakamichi, Yasuhide Yamada, Tillmann Taube, Hiroshi Wakui, Yutaka Fujiwara
المصدر: Investigational New Drugs. 34:66-74
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Maximum Tolerated Dose, Nausea, Antineoplastic Agents, Pharmacology, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Asian People, Pharmacokinetics, Neoplasms, Internal medicine, medicine, Clinical endpoint, Humans, Pharmacology (medical), Infusions, Intravenous, Adverse effect, Protein Kinase Inhibitors, Aged, Dose Modification, Dose-Response Relationship, Drug, business.industry, Pteridines, Volasertib, Middle Aged, medicine.disease, Clinical trial, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Female, medicine.symptom, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c175872e4d3a4fe79938bb0a1b9e3bfTest
https://doi.org/10.1007/s10637-015-0300-0Test -
4
المؤلفون: Hidenori Mizugaki, Osamu Nakamura, Tomohide Tamura, Shinji Nakamichi, Yutaka Fujiwara, Hiroshi Nokihara, Eri Inukai, Satoru Kitazono, Yasuhide Yamada, Noboru Yamamoto
المصدر: Cancer Chemotherapy and Pharmacology. 75:1155-1161
مصطلحات موضوعية: Adult, Male, Drug, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, media_common.quotation_subject, Pharmacology, Neutropenia, Hydroxamic Acids, Toxicology, Gastroenterology, Drug Administration Schedule, chemistry.chemical_compound, Asian People, Resminostat, Leukocytopenia, Pharmacokinetics, Neoplasms, Internal medicine, medicine, Humans, Pharmacology (medical), Aged, media_common, Sulfonamides, business.industry, Middle Aged, medicine.disease, Discontinuation, Histone Deacetylase Inhibitors, Oncology, chemistry, Pharmacodynamics, Female, Lymphocytopenia, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a139a406640775311593de37a18df67Test
https://doi.org/10.1007/s00280-015-2741-8Test -
5
المؤلفون: Tomohide Tamura, Yuko Tanabe, Noboru Yamamoto, Shigenobu Suzuki, Yosuke Tamura, Hiroshi Wakui, Naoya Yamazaki, Yoshitaka Ogita, Hajime Asahina, Hidenori Mizugaki, Yutaka Fujiwara, Satoru Kitazono, Kazunori Honda, Yasuhide Yamada, Shinji Nakamichi, Hiroshi Nokihara, Mieko Matsuoka
المصدر: Investigational New Drugs. 33:641-651
مصطلحات موضوعية: Adult, Male, Antineoplastic Agents, Pharmacology, MEK Inhibitor RO4987655, Asian People, Pharmacokinetics, Neoplasms, Oxazines, Biomarkers, Tumor, Humans, Medicine, Pharmacology (medical), Dosing, Adverse effect, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Aged, 80 and over, Mitogen-Activated Protein Kinase Kinases, biology, business.industry, MEK inhibitor, Middle Aged, Treatment Outcome, Oncology, Pharmacodynamics, Benzamides, biology.protein, Eye disorder, Female, Creatine kinase, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b208b9f4a56c8e79fb89bdcdd3026f87Test
https://doi.org/10.1007/s10637-015-0229-3Test